OCGN may soon become an aquisition Target

AdairHoratio
2021-11-08

There is a 15 billion dose demand for a long term memory cell response vaccine that provides lifelong protection after 3 doses.
Gene therapies will require 2 booster shots a year for life. Nobody wants this anymore.
OCGN may soon become an aquisition Target because of the merit of it's American produced and OCGN owned vaccine named COVAXIN!

$Histogenics(OCGN)$

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法